Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.
Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.
FDA-approved naltrexone (Vivitrol) blocks the rewarding effects of opioids and alcohol — eliminating the biochemical reinforcement that drives relapse. Non-addictive, no tapering required, effective for both opioid and alcohol use disorder. Integrated with therapy at Compass Recovery in Cypress, CA — close to Lakewood.
Available 24/7 for Lakewood residents — (949) 444-9047
Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.
For many people in Lakewood struggling with opioid or alcohol addiction, the urge to use isn't simply a matter of willpower. It's a neurological pattern: the brain has learned to crave the reward response that comes with use. Naltrexone (Vivitrol) works by blocking opioid receptors in the brain, interrupting that reward cycle at its source. With the opioid crisis continuing to impact Southern California communities, and limited access to medication-assisted treatment options in this region, having Naltrexone treatment available nearby offers Lakewood residents a direct path to address the biology driving relapse.
Compass Recovery's Naltrexone program in nearby Cypress integrates this non-addictive medication with individual counseling, group therapy, dual diagnosis care, and our Purpose Discovery Program to address both the physical and psychological sides of addiction. Unlike Suboxone, Naltrexone is an opioid antagonist rather than an agonist, meaning it carries no physical dependence, requires no tapering process, and works for both opioid and alcohol use disorder. It's one of the few FDA-approved treatments that gives you real choice in your recovery path.
Naltrexone is FDA-approved for opioid and alcohol use disorder. It is particularly well-suited for clients where several of these apply.
Naltrexone is available as a daily oral tablet (Revia) or a monthly extended-release injection (Vivitrol). Both block opioid and alcohol reward. Our clinical team determines which form is the right fit based on your history, lifestyle, and treatment goals.
A daily 50mg tablet that maintains a consistent opioid and alcohol block. Effective and lower cost, but depends on daily adherence — which can become a vulnerability during high-stress or high-craving periods.
A once-monthly intramuscular injection that provides continuous naltrexone coverage without daily pill decisions. Removes the daily adherence barrier — the most common reason oral naltrexone fails — and is particularly effective during the highest-risk relapse windows after discharge.
Lakewood has a significant professional population in healthcare, law enforcement, and legal fields where maintaining a non-controlled medication status is essential for career requirements and licensing. Compass Recovery understands these constraints and specializes in naltrexone treatment, offering the medication-assisted path that respects your professional standing while addressing opioid use disorder with real effectiveness. We're here to support your recovery without compromise.
Naltrexone is an opioid antagonist — it blocks receptors rather than activating them. No physical dependence, no withdrawal on discontinuation, no controlled substance classification. It cannot be misused.
One of the few FDA-approved medications effective for both opioid use disorder and alcohol use disorder. A single treatment option for clients with complex or dual substance histories.
Naltrexone is prescribed and monitored by our licensed clinical team. Both oral and Vivitrol injection forms are available, with dosing and form determined by your clinical profile.
Depression, anxiety, PTSD, and trauma frequently co-occur with opioid and alcohol use disorder. Our team treats both simultaneously — not as separate referrals at a later stage.
Our signature program helps every client identify their life purpose and build a future they genuinely want — giving recovery a compelling reason that medication and willpower alone cannot provide.
California DHCS licensed (No. 300331CP) and Joint Commission accredited. Our Naltrexone program meets the highest clinical and regulatory standards for behavioral health in California.
Our admissions team answers 24/7. We will assess your situation, verify your insurance, and arrange a clinical evaluation for Naltrexone or Vivitrol — close to Lakewood.
From your first call to your first dose or injection, here is exactly what happens when you reach out to Compass Recovery.
Call (949) 444-9047 any time. We review your substance use history, current health, and whether you have completed the opioid-free period required before Naltrexone induction.
We confirm your Aetna, Blue Shield, Cigna, TriWest, or other benefits at no cost. Both oral Naltrexone and Vivitrol injection are covered under most major plans.
A licensed prescriber confirms you are opioid-free, assesses liver function, and determines the right form (oral vs Vivitrol) and dosing schedule for your clinical situation.
First dose or Vivitrol injection at our Cypress facility, accessible from Lakewood. Therapy begins alongside medication from day one across all levels of care.
Naltrexone quiets the brain's craving response while our Lakewood-area therapy addresses what drives your use, and whenever you're ready to explore what's possible, our team is here without judgment or pressure.
Available 24 hours • 7 days a week • Cypress, Orange County, CA
Accredited/Certified by The Joint Commission.
Compass Recovery, Inc.
9431 & 9432 Alderbury St., Cypress, CA 90630
California DHCS License No. 300331CP, expires 11/30/2027
Joint Commission HCO ID 603196
Compass Recovery protects patient information in accordance with HIPAA, 42 CFR Part 2, and California law. View our Notice of Privacy Practices.